Koning
Private Company
Total funding raised: $30M
Overview
Koning is a private medical device company that has developed an innovative breast imaging system, the Koning Vera Breast CT (KBCT). This device utilizes cone-beam CT technology to generate true 3D images of the breast in under 10 seconds without compression, at radiation doses comparable to diagnostic mammography. The company targets the significant limitations of standard mammography, particularly its high miss rates in dense breast tissue, with a goal of improving early detection and patient experience. Koning holds over 120 patents globally and is in the commercial rollout phase, placing devices in imaging centers worldwide.
Technology Platform
Cone-beam computed tomography (CT) for dedicated, high-resolution, true 3D breast imaging without compression.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Koning competes with established giants in mammography and breast tomosynthesis (Hologic, GE, Siemens) and other advanced modalities like breast MRI. Its differentiation is no-compression, true 3D imaging at a low dose, but it faces significant challenges in displacing deeply entrenched technologies with vast sales and service networks.